- Home
- BPMC vs ZWS Comparison
BPMC vs ZWS Comparison
Compare BPMC & ZWS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- ZWS
- Stock Information
- Founded
- BPMC 2008
- ZWS 1891
- Country
- BPMC United States
- ZWS United States
- Employees
- BPMC N/A
- ZWS N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- ZWS Industrial Machinery/Components
- Sector
- BPMC Health Care
- ZWS Industrials
- Exchange
- BPMC Nasdaq
- ZWS Nasdaq
- Market Cap
- BPMC 5.8B
- ZWS 6.1B
- IPO Year
- BPMC 2015
- ZWS 2012
- Fundamental
- Price
- BPMC $88.51
- ZWS $32.98
- Analyst Decision
- BPMC Buy
- ZWS Buy
- Analyst Count
- BPMC 22
- ZWS 5
- Target Price
- BPMC $124.29
- ZWS $38.40
- AVG Volume (30 Days)
- BPMC 958.8K
- ZWS 911.7K
- Earning Date
- BPMC 05-01-2025
- ZWS 04-22-2025
- Dividend Yield
- BPMC N/A
- ZWS 1.11%
- EPS Growth
- BPMC N/A
- ZWS 43.81
- EPS
- BPMC N/A
- ZWS 0.92
- Revenue
- BPMC $508,824,000.00
- ZWS $1,566,500,000.00
- Revenue This Year
- BPMC $45.43
- ZWS $4.37
- Revenue Next Year
- BPMC $32.80
- ZWS $5.14
- P/E Ratio
- BPMC N/A
- ZWS $36.22
- Revenue Growth
- BPMC 104.04
- ZWS 2.35
- 52 Week Low
- BPMC $80.68
- ZWS $28.25
- 52 Week High
- BPMC $121.90
- ZWS $41.15
- Technical
- Relative Strength Index (RSI)
- BPMC 43.04
- ZWS 38.40
- Support Level
- BPMC $86.99
- ZWS $32.91
- Resistance Level
- BPMC $93.04
- ZWS $34.49
- Average True Range (ATR)
- BPMC 3.36
- ZWS 0.69
- MACD
- BPMC 0.32
- ZWS 0.08
- Stochastic Oscillator
- BPMC 29.62
- ZWS 37.86
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About ZWS Zurn Elkay Water Solutions Corporation
Zurn Elkay Water Solutions Corp designs procure, manufactures, and markets a range of clean water solutions for drinking water, hygiene, and sustainable water management. The Zurn Elkay product portfolio includes professional-grade water control and safety, water distribution and drainage, drinking water, finish plumbing, hygienic, environmental and site works products for public and private spaces.